stockrow
Friday 6 November 2026
Export HCAT’s income statement to Excel — free account
Health Catalyst, Inc.
HCAT Healthcare Health Information Services
Health Catalyst, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $311.1 million, up 1.48% from fiscal 2024.
- Revenue
- −26.3%
- EPS
- +268.8%
- Free cash flow
- +65.6%
- Total debt
- +0.29%
Quarter to September 2026, against a year earlier
1.47
0.03
−2.00%
Follow HCAT
Alert me
| Sep '26 From the 10-Q filed 5 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 5 | 5 | 5 |
+8 more TTM periods Free account |
| (84.64%) | (118.12%) | (103.02%) | (58.26%) | ||
| (49.02%) | (54.33%) | (40.69%) | (26.14%) | ||
ROIC |
(167.90%) | (102.14%) | (84.56%) | (33.15%) | |
Return on Tangible Assets |
(226.37%) | (139.42%) | (241.95%) | (156.71%) | |
Average Days of Receivables |
55.42 | 52.33 | 71.37 | 69.36 | |
Free Cash Flow per Share |
0.34 | 0.09 | (0.04) | (0.30) | |
Free Cash Flow |
25.73 | 6.59 | (2.71) | (20.78) | |
Capital Expenditures |
(1.09) | (21.65) | (21.68) | (21.51) | |
| Other line items | |||||
Cash ROIC |
11.46% | 1.84% | (0.68%) | (4.20%) | |
Accounts Receivable Turnover |
5.37 | 5.30 | 4.91 | 5.35 | |
Accounts Payable Turnover |
24.13 | 16.75 | 14.69 | 15.34 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
17.22 | 21.03 | 28.16 | 21.43 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
14.78% | 14.71% | 14.67% | 16.00% | |
Selling, General and Administrative Expense of Revenue |
32.55% | 33.70% | 32.29% | 32.79% | |
Share Based Compensation of Revenue |
5.39% | 6.03% | 7.68% | 8.68% | |
Interest Coverage |
(13.78) | (14.40) | (14.38) | (9.81) | |
Operating CF/Net income |
(0.13) | (0.11) | (0.07) | 0.00 | |
Depreciation/Fixed assets |
0.00 | 7.63 | 7.42 | 4.86 | |
Capex/Depreciation |
0.00 | (0.08) | (0.08) | (0.13) | |
Revenue per Share |
3.58 | 3.95 | 4.17 | 4.45 | |
Operating CF per Share |
0.35 | 0.38 | 0.26 | 0.01 | |
Capex per Share |
(0.01) | (0.29) | (0.30) | (0.31) | |
Capex to Sales |
0.00 | 0.07 | 0.07 | 0.07 |
Columns are period end dates · fundamentals updated 5 Nov 2026